Valeant Pharma Back Over $30

Valenat Pharma

shares are trading higher by $2.05 at $30.50 in Wednesday's session. The Street is breathing a sigh of relief now that the company has disclosed it will release its Q4 report on June 7 and will follow with a conference call to discuss them. After a few quiet sessions, the issue found support just above Tuesday's low ($28.23), only reaching $28.27 before turning higher. So far, the issue has climbed into the $30 handle for the first time since May 9, when it peaked at $31. At this time, the high for the day stands at $30.87.